A detailed history of Pathstone Family Office, LLC transactions in Penumbra Inc stock. As of the latest transaction made, Pathstone Family Office, LLC holds 1,976 shares of PEN stock, worth $377,080. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,976
Previous 840 135.24%
Holding current value
$377,080
Previous $289,000 65.4%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$240.69 - $338.77 $273,423 - $384,842
1,136 Added 135.24%
1,976 $478,000
Q2 2023

Jan 12, 2024

SELL
$271.54 - $344.06 $308,469 - $390,852
-1,136 Reduced 57.49%
840 $289,000
Q2 2023

Aug 14, 2023

SELL
$271.54 - $344.06 $51,864 - $65,715
-191 Reduced 18.53%
840 $289,000
Q1 2023

May 15, 2023

SELL
$220.43 - $278.69 $165,763 - $209,574
-752 Reduced 42.18%
1,031 $287,000
Q4 2022

Oct 23, 2023

BUY
$151.88 - $228.5 $143,222 - $215,475
943 Added 112.26%
1,783 $396,000
Q4 2022

Feb 13, 2023

BUY
$151.88 - $228.5 $109,353 - $164,520
720 Added 67.73%
1,783 $396,000
Q3 2022

Nov 14, 2022

BUY
$120.36 - $205.88 $127,942 - $218,850
1,063 New
1,063 $201,000
Q2 2022

Aug 15, 2022

SELL
$116.09 - $227.33 $155,328 - $304,167
-1,338 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$187.51 - $283.98 $12,000 - $18,174
-64 Reduced 4.56%
1,338 $349,000
Q4 2021

Feb 14, 2022

BUY
$238.08 - $288.0 $1,190 - $1,440
5 Added 0.36%
1,402 $403,000
Q3 2021

Nov 16, 2021

BUY
$250.72 - $291.24 $81,484 - $94,653
325 Added 30.32%
1,397 $372,000
Q2 2021

Aug 31, 2021

BUY
$235.0 - $310.7 $14,805 - $19,574
63 Added 6.24%
1,072 $294,000
Q1 2021

May 14, 2021

BUY
$175.6 - $291.43 $177,180 - $294,052
1,009 New
1,009 $273,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $7.23B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Pathstone Family Office, LLC Portfolio

Follow Pathstone Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.